Status:
RECRUITING
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Lead Sponsor:
Helmholtz Zentrum München
Conditions:
Identification of Infants at Risk for Type 1 Diabetes
Eligibility:
All Genders
1-6 years
Brief Summary
The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.
Detailed Description
Type 1 diabetes is a common chronic disease in childhood and is increasing in incidence. Type 1 diabetes is diagnosed by hyperglycemia often in combination with symptoms of weight loss, thirst, fatigu...
Eligibility Criteria
Inclusion
- Age: up to age 6 weeks
- provided written informed consent by custodial parent
Exclusion
- \-
Key Trial Info
Start Date :
October 19 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
1000000 Patients enrolled
Trial Details
Trial ID
NCT03316261
Start Date
October 19 2017
End Date
August 1 2027
Last Update
December 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut für Diabetesforschung, Helmholtz Zentrum München
Munich, Germany